3-year update on the ELOQUENT-2 clinical trial of elotuzumab in multiple myeloma
Debate on the use of MRD for multiple myeloma management
Bruno Paiva et al.
SWOG S0777 trial: lenalidomide, dexamethasone and bortezomib for the treatment of MM
Breaking news from the ALCYONE study of VMP plus daratumumab for NDMM
Maria Victoria Mateos
Temsirolimus with BERT for the treatment of relapsed mantle cell and follicular lymphoma